Muzinich Weekly Market Comment: U-turns
  • 2 days ago

It was a short week due to the Thanksgiving holiday in the US. However, market price action was supportive as positive sentiment returned and our preferred sentiment index, the VIX, fell sharply ba...

Tech making you queasy? Healthcare could be the cure
  • 5 days ago

If you pick up a newspaper today, it is likely that you will find an article either proclaiming or disputing the existence of an AI bubble. As Chart 1 shows, in the week commencing the 17 October,...

Emerging Markets: October Monthly Commentary
  • 6 days ago

During October the strategy lagged the MSCI Emerging Markets index by 0.8%, even as markets continued rallying. This was primarily due stock selection in Taiwan, where TSMC continued setting the pa...

G10 Macro Rates: October Monthly Commentary
  • 6 days ago

October net performance was a positive +0.59%. The month was more active after the summer doldrums, kicked off by a spat between the US and China over access to rare earth metals and Trumps’ immedi...

Emerging Markets Income: October Monthly Commentary
  • 6 days ago

The fund rose 4.4% in October. South Korea remains the standout performer, and together with good returns from Taiwan made Technology the strongest performing sector.

Global Active Credit: October Monthly Commentary
  • 6 days ago

October saw strong equity market performance globally, accompanied by a rally in global risk-free rates. The S&P 500 gained 2.3%, while the Nasdaq rose 4.8%. In Europe, major indices also finished...

Emerging Market Debt Commentary: October 2025
  • 7 days ago

EM debt gained on robust demand, easing inflation, a Fed cut, and trade deal progress—offsetting lingering geopolitical worries and country-specific issues.

Weekly Market Commentary | November 24 2025
  • 8 days ago

Stocks: S&P 500’s Losing Streak Hits Three Weeks; Attractive Valuations, Sector Exposures Are Feathers In The Cap Of U.S. Mid-Caps; U.S. Dollar Strength Weighs On Developed Market Stocks Abroad.

Wilshire Quarterly Alternatives Commentary - Third Quarter 2025
  • 8 days ago

Investment Research